US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2020 (6 years ago)

Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.

What was recalled

Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India, NDC 68180-723-20

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-723-20
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1406-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cefdinir recalls

See all